Picture of Evolus logo

EOLS — Evolus News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Evolus Inc reports results for the quarter ended in December - Earnings Summary

* Evolus Inc  EOLS.OQ  reported a quarterly adjusted loss
of 12
cents​​ per share for the quarter ended in December, higher than
the same quarter last year, when the company reported EPS of -14
cents.  The mean expectation of eight analysts for the quarter
was for a loss of 7 cents per share. Wall Street expected
results to range from -9 cents to -5 cents per share.
    * Revenue rose 39.8% to $61.00 million from a year ago;
analysts
expected $60.06 million. 
    * Evolus Inc's reported EPS for the quarter was a loss of 21
cents​.
    * The company reported a quarterly loss of $11.83 million.
    * Evolus Inc shares had risen by 34.0% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 27.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * Wall Street's median 12-month price target for Evolus Inc
is
$22.00 

This summary was machine generated from LSEG data March 8 at
12:13 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.07          -0.12          Missed
 Sep. 30 2023      -0.17          -0.16          Beat
 Jun. 30 2023      -0.19          -0.19          Met
 Mar. 31 2023      -0.15          -0.15          Met

Recent news on Evolus

See all news